Drug Lobby Says Athena Ruling May Zap Biotech Funding
Biotech and pharmaceutical industry groups urged the full Federal Circuit on Monday to rethink a February ruling that nixed Athena Diagnostics' patent on an autoimmune disease testing method, saying the ruling threatens U.S....To view the full article, register now.
Already a subscriber? Click here to view full article